Another ongoing study explores the potential benefits of combining metronidazole with postoperative chemotherapy in patients with high levels of Fn. Researchers aim to determine whether reducing this bacterium can enhance the effectiveness of chemotherapy in CRC treatment (Fang, 2020). The gene discussed is FN1; the disease is colorectal carcinoma.